Replimune Group Stock Performance

Replimune Relative Risk vs. Return Landscape

If you would invest  1,021  in Replimune Group on October 29, 2025 and sell it today you would lose (265.00) from holding Replimune Group or give up 25.95% of portfolio value over 90 days. Replimune Group is currently does not generate positive expected returns and assumes 3.3466% risk (volatility on return distribution) over the 90 days horizon. In different words, 30% of stocks are less volatile than Replimune, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.Given the investment horizon of 90 days Replimune is expected to under-perform the market. In addition to that, the company is 4.48 times more volatile than its market benchmark. It trades about -0.13 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.09 per unit of volatility.

Replimune Target Price Odds to finish over Current Price

Given the investment horizon of 90 days Replimune has a beta of 0.89 indicating Replimune Group market returns are very sensitive to returns on the market. As the market goes up or down, Replimune is expected to follow. Additionally Replimune Group has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.

Predictive Modules for Replimune

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Replimune Group. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 4.23 7.56 10.89 Details

Intrinsic Valuation Low Real High 3.98 7.31 10.64 Details

Naive Forecast Low Next High 4.31 7.63 10.96 Details

8 Analysts Consensus Low Target High 11.44 12.57 13.95 Details

Replimune Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Replimune is not an exception. The market had few large corrections towards the Replimune's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Replimune Group, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Replimune within the framework of very fundamental risk indicators.

Replimune Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Replimune for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Replimune Group can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Replimune Price Density Drivers

Replimune Fundamentals Growth

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Replimune Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Replimune. If investors know Replimune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Replimune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Replimune Group is measured differently than its book value, which is the value of Replimune that is recorded on the company's balance sheet. Investors also form their own opinion of Replimune's value that differs from its market value or its book value, called intrinsic value, which is Replimune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Replimune's market value can be influenced by many factors that don't directly affect Replimune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Replimune's value and its price as these two are different measures arrived at by different means. Investors typically determine if Replimune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Replimune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.